Will an mRNA cancer vaccine receive regulatory approval for a cancer indication by 2030?
Market says 50% YES right now. Closes 31 Dec 2030.
Predict whether a personalized or shared-antigen mRNA cancer vaccine will receive formal regulatory approval for at least one cancer indication before 2031.
How this market resolves
YES requires approval from a recognized national medicines regulator for a defined cancer indication, not merely trial authorization.
Category: Tech & Science